![profile-img](https://pbs.twimg.com/profile_images/950370379159175169/pPulPiOS_200x200.jpg)
NCI CTEP Clinical Research
@NCICTEP_ClinRes
Official Twitter account of NCI's Cancer Therapy Evaluation Program, providing updates to our trials research community. Part of @NIH. Privacy: https://t.co/9Aox3geiD8
08-01-2018 14:11:10
1,1K Tweets
3,2K Followers
92 Following
![NCI CTEP Clinical Research(@NCICTEP_ClinRes) 's Twitter Profile Photo NCI CTEP Clinical Research(@NCICTEP_ClinRes) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/950370379159175169/pPulPiOS_200x200.jpg)
Newly Activated #NCTN #Myeloma Trial: (A062102) Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients, led by Dr. Tuchman Sascha Tuchman UNC Lineberger Alliance for Clinical Trials in Oncology Learn more: buff.ly/4d0v0cM
![NCI CTEP Clinical Research (@NCICTEP_ClinRes) on Twitter photo 2024-04-16 14:01:11 Newly Activated #NCTN #Myeloma Trial: (A062102) Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients, led by Dr. Tuchman @stuchman1 @UNC_Lineberger @ALLIANCE_org Learn more: buff.ly/4d0v0cM Newly Activated #NCTN #Myeloma Trial: (A062102) Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients, led by Dr. Tuchman @stuchman1 @UNC_Lineberger @ALLIANCE_org Learn more: buff.ly/4d0v0cM](https://pbs.twimg.com/media/GLSqSa_WAAAx-6F.jpg)